Cancer Research Targets Advances in Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
[Cancer Research 59, 3352-3356, July 1, 1999]
© 1999 American Association for Cancer Research
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by G. Corn, P.
Right arrow Articles by G. Herman, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by G. Corn, P.
Right arrow Articles by G. Herman, J.
[Cancer Research 59, 3352-3356, July 15, 1999]
© 1999 American Association for Cancer Research

Advances in Brief

Transcriptional Silencing of the p73 Gene in Acute Lymphoblastic Leukemia and Burkitt’s Lymphoma Is Associated with 5' CpG Island Methylation1

Paul G. Corn2, Steven J. Kuerbitz2, Max M. van Noesel, Manel Esteller, Nicole Compitello, Stephen B. Baylin and James G. Herman3

The Johns Hopkins Oncology Center, Baltimore, Maryland 21231 [P. G. C., M. E., S. B. B., J. G. H.]; Academic Medical Center, Department of Human Genetics-M1, 1105 AZ Amsterdam, the Netherlands [M. M. v. N.]; and Pediatric Hematology and Oncology, Rainbow Babies and Children’s Hospital [S. J. K., N. C.], and the Department of Human Genetics [S. J. K.], Case Western Reserve University, Cleveland, Ohio 44106

he p73 gene is located on 1p36.2-3, a region that is frequently deleted in human cancer. Because p73 encodes for a protein that is both structurally and functionally homologous to the p53 protein, p73 has been postulated to be a candidate tumor suppressor gene. To date, however, mutations of p73 have not been found. To study methylation of the p73 5'CpG island, a human bacterial artificial chromosome clone containing exon 1 and the 5' region of p73 was isolated. There was no evidence for p73 exon 1 methylation in normal tissues. In contrast, p73 was aberrantly methylated in approximately 30% of primary acute lymphoblastic leukemias (ALLs) and Burkitt’s lymphomas. There was no evidence for methylation in any other types of hematological malignancies or solid tumors examined. In both leukemia cell lines and primary ALLs, methylation was associated with transcriptional loss of p73 by reverse transcription-PCR. We used single-strand conformational polymorphisms to screen for point mutations in a series of primary ALLs and found no mutations leading to a change in protein structure. Our results show that methylation of p73 is a frequent event in specific types of hematological malignancies and suggest that epigenetic silencing of p73 could have important consequences for cell-cycle regulation.




This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
P. H. Rao, D. Roberts, Y.-J. Zhao, D. Bell, C. P. Harris, R. S. Weber, and A. K. El-Naggar
Deletion of 1p32-p36 Is the Most Frequent Genetic Change and Poor Prognostic Marker in Adenoid Cystic Carcinoma of the Salivary Glands
Clin. Cancer Res., August 15, 2008; 14(16): 5181 - 5187.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
H. Kroeger, J. Jelinek, M. R. H. Estecio, R. He, K. Kondo, W. Chung, L. Zhang, L. Shen, H. M. Kantarjian, C. E. Bueso-Ramos, et al.
Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse
Blood, August 15, 2008; 112(4): 1366 - 1373.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. Shen, Y. Kondo, S. Ahmed, Y. Boumber, K. Konishi, Y. Guo, X. Chen, J. N. Vilaythong, and J.-P. J. Issa
Drug Sensitivity Prediction by CpG Island Methylation Profile in the NCI-60 Cancer Cell Line Panel
Cancer Res., December 1, 2007; 67(23): 11335 - 11343.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Wang, Y.-X. Liu, M. P. Hande, A. C. Wong, Y. J. Jin, and Y. Yin
TAp73 Is a Downstream Target of p53 in Controlling the Cellular Defense against Stress
J. Biol. Chem., October 5, 2007; 282(40): 29152 - 29162.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
E. H. Jensen, J. M. Lewis, J. M. McLoughlin, M. D. Alvarado, A. Daud, J. Messina, S. Enkemann, T. J. Yeatman, V. K. Sondak, and A. I. Riker
Down-Regulation of Pro-Apoptotic Genes is an Early Event in the Progression of Malignant Melanoma
Ann. Surg. Oncol., April 1, 2007; 14(4): 1416 - 1423.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
V. F. Chekhun, N. Y. Lukyanova, O. Kovalchuk, V. P. Tryndyak, and I. P. Pogribny
Epigenetic profiling of multidrug-resistant human MCF-7 breast adenocarcinoma cells reveals novel hyper- and hypomethylated targets
Mol. Cancer Ther., March 1, 2007; 6(3): 1089 - 1098.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
J J L Wong, N J Hawkins, and R L Ward
Colorectal cancer: a model for epigenetic tumorigenesis
Gut, January 1, 2007; 56(1): 140 - 148.
[Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. Mulero-Navarro, J.M. Carvajal-Gonzalez, M. Herranz, E. Ballestar, M.F. Fraga, S. Ropero, M. Esteller, and P.M. Fernandez-Salguero
The dioxin receptor is silenced by promoter hypermethylation in human acute lymphoblastic leukemia through inhibition of Sp1 binding
Carcinogenesis, May 1, 2006; 27(5): 1099 - 1104.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C. Bueso-Ramos, Y. Xu, T. J. McDonnell, S. Brisbay, S. Pierce, H. Kantarjian, G. Rosner, and G. Garcia-Manero
Protein Expression of a Triad of Frequently Methylated Genes, p73, p57Kip2, and p15, Has Prognostic Value in Adult Acute Lymphocytic Leukemia Independently of Its Methylation Status
J. Clin. Oncol., June 10, 2005; 23(17): 3932 - 3939.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
Y. Sun, S. Orrenius, S. Pervaiz, and B. Fadeel
Plasma membrane sequestration of apoptotic protease-activating factor-1 in human B-lymphoma cells: a novel mechanism of chemoresistance
Blood, May 15, 2005; 105(10): 4070 - 4077.
[Abstract] [Full Text] [PDF]

Home page
 Cold Spring Harb Symp Quant BiolHome page
J.G. HERMAN
Epigenetic Changes in Cancer and Preneoplasia
Cold Spring Harb Symp Quant Biol, January 1, 2005; 70(0): 329 - 333.
[Abstract] [PDF]

Home page
 Clin. Cancer Res.Home page
Q. Yang, P. Zage, D. Kagan, Y. Tian, R. Seshadri, H. R. Salwen, S. Liu, A. Chlenski, and S. L. Cohn
Association of Epigenetic Inactivation of RASSF1A with Poor Outcome in Human Neuroblastoma
Clin. Cancer Res., December 15, 2004; 10(24): 8493 - 8500.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Ushmorov, O. Ritz, M. Hummel, F. Leithauser, P. Moller, H. Stein, and T. Wirth
Epigenetic silencing of the immunoglobulin heavy-chain gene in classical Hodgkin lymphoma-derived cell lines contributes to the loss of immunoglobulin expression
Blood, November 15, 2004; 104(10): 3326 - 3334.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. Takahashi, N. Shivapurkar, E. Riquelme, H. Shigematsu, J. Reddy, M. Suzuki, K. Miyajima, X. Zhou, B. N. Bekele, A. F. Gazdar, et al.
Aberrant Promoter Hypermethylation of Multiple Genes in Gallbladder Carcinoma and Chronic Cholecystitis
Clin. Cancer Res., September 15, 2004; 10(18): 6126 - 6133.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
U. M. Moll and N. Slade
p63 and p73: Roles in Development and Tumor Formation
Mol. Cancer Res., July 1, 2004; 2(7): 371 - 386.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
F. Bernassola, P. Salomoni, A. Oberst, C. J. Di Como, M. Pagano, G. Melino, and P. P. Pandolfi
Ubiquitin-dependent Degradation of p73 Is Inhibited by PML
J. Exp. Med., June 7, 2004; 199(11): 1545 - 1557.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. S. Liu, R. C.-Y. Leung, K. Y.-K. Chan, P.-M. Chiu, A. N.-Y. Cheung, K.-F. Tam, T.-Y. Ng, L.-C. Wong, and H. Y.-S. Ngan
p73 Expression Is Associated with the Cellular Radiosensitivity in Cervical Cancer after Radiotherapy
Clin. Cancer Res., May 15, 2004; 10(10): 3309 - 3316.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. Takahashi, N. Shivapurkar, J. Reddy, H. Shigematsu, K. Miyajima, M. Suzuki, S. Toyooka, S. Zochbauer-Muller, J. Drach, G. Parikh, et al.
DNA Methylation Profiles of Lymphoid and Hematopoietic Malignancies
Clin. Cancer Res., May 1, 2004; 10(9): 2928 - 2935.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. Atadja, L. Gao, P. Kwon, N. Trogani, H. Walker, M. Hsu, L. Yeleswarapu, N. Chandramouli, L. Perez, R. Versace, et al.
Selective Growth Inhibition of Tumor Cells by a Novel Histone Deacetylase Inhibitor, NVP-LAQ824
Cancer Res., January 15, 2004; 64(2): 689 - 695.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Sasaki, H. Mita, M. Toyota, S. Ishida, I. Morimoto, T. Yamashita, T. Tanaka, K. Imai, Y. Nakamura, and T. Tokino
Identification of the Interleukin 4 Receptor {alpha} Gene as a Direct Target for p73
Cancer Res., December 1, 2003; 63(23): 8145 - 8152.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
J. G. Herman and S. B. Baylin
Gene Silencing in Cancer in Association with Promoter Hypermethylation
N. Engl. J. Med., November 20, 2003; 349(21): 2042 - 2054.
[Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
M. Marabese, F. Vikhanskaya, C. Rainelli, T. Sakai, and M. Broggini
DNA damage induces transcriptional activation of p73 by removing C-EBP{alpha} repression on E2F1
Nucleic Acids Res., November 15, 2003; 31(22): 6624 - 6632.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
U. M. Moll
The Role of p63 and p73 in Tumor Formation and Progression: Coming of Age Toward Clinical Usefulness: Commentary re: F. Koga et al., Impaired p63 Expression Associates with Poor Prognosis and Uroplakin III Expression in Invasive Urothelial Carcinoma of the Bladder. Clin. Cancer Res., 9: 5501-5507, 2003, and P. Puig et al., p73 Expression in Human Normal and Tumor Tissues: Loss of p73{alpha} Expression Is Associated with Tumor Progression in Bladder Cancer. Clin. Cancer Res., 9: 5642-5651, 2003.
Clin. Cancer Res., November 15, 2003; 9(15): 5437 - 5441.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
P. Gonzalez-Gomez, M. J. Bello, M. E. Alonso, J. Lomas, D. Arjona, J. M. d. Campos, J. Vaquero, A. Isla, L. Lassaletta, M. Gutierrez, et al.
CpG Island Methylation in Sporadic and Neurofibromatis Type 2-Associated Schwannomas
Clin. Cancer Res., November 15, 2003; 9(15): 5601 - 5606.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
L. Shen, M. Toyota, Y. Kondo, T. Obata, S. Daniel, S. Pierce, K. Imai, H. M. Kantarjian, J.-P. J. Issa, and G. Garcia-Manero
Aberrant DNA methylation of p57KIP2 identifies a cell-cycle regulatory pathway with prognostic impact in adult acute lymphocytic leukemia
Blood, May 15, 2003; 101(10): 4131 - 4136.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
W. J. Freebern, J. L. Smith, S. S. Chaudhry, C. M. Haggerty, and K. Gardner
Novel Cell-specific and Dominant Negative Anti-apoptotic Roles of p73 in Transformed Leukemia Cells
J. Biol. Chem., January 17, 2003; 278(4): 2249 - 2255.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
P. G. Corn, M. K. Summers, F. Fogt, A. K. Virmani, A. F. Gazdar, T. D. Halazonetis, and W. S. El-Deiry
Frequent hypermethylation of the 5' CpG island of the mitotic stress checkpoint gene Chfr in colorectal and non-small cell lung cancer
Carcinogenesis, January 1, 2003; 24(1): 47 - 51.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
S A Pileri, E Sabattini, P Rosito, P L Zinzani, S Ascani, G Fraternali-Orcioni, B Gamberi, M Piccioli, D Vivenza, B Falini, et al.
Primary follicular lymphoma of the testis in childhood: an entity with peculiar clinical and molecular characteristics
J. Clin. Pathol., September 1, 2002; 55(9): 684 - 688.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
A. Gloghini, G. Gaidano, L. M. Larocca, F. Pierconti, A. Cingolani, L. Dal Maso, D. Capello, S. Franceschi, U. Tirelli, M. Libra, et al.
Expression of Cyclin-Dependent Kinase Inhibitor p27Kip1 in AIDS-Related Diffuse Large-Cell Lymphomas Is Associated with Epstein-Barr Virus-Encoded Latent Membrane Protein 1
Am. J. Pathol., July 1, 2002; 161(1): 163 - 171.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
G. Garcia-Manero, J. Daniel, T. L. Smith, S. M. Kornblau, M.-S. Lee, H. M. Kantarjian, and J.-P. J. Issa
DNA Methylation of Multiple Promoter-associated CpG Islands in Adult Acute Lymphocytic Leukemia
Clin. Cancer Res., July 1, 2002; 8(7): 2217 - 2224.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
G. Garcia-Manero, C. Bueso-Ramos, J. Daniel, J. Williamson, H. M. Kantarjian, and J.-P. J. Issa
DNA Methylation Patterns at Relapse in Adult Acute Lymphocytic Leukemia
Clin. Cancer Res., June 1, 2002; 8(6): 1897 - 1903.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
N. Konishi, M. Nakamura, M. Kishi, M. Nishimine, E. Ishida, and K. Shimada
Heterogeneous Methylation and Deletion Patterns of the INK4a/ARF Locus Within Prostate Carcinomas
Am. J. Pathol., April 1, 2002; 160(4): 1207 - 1214.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. Balint, A. C. Phillips, S. Kozlov, C. L. Stewart, and K. H. Vousden
Induction of p57KIP2 expression by p73beta
PNAS, March 19, 2002; 99(6): 3529 - 3534.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
L. L. Ping Siu, J. K. Cheung Chan, K.-F. Wong, and Y.-L. Kwong
Specific Patterns of Gene Methylation in Natural Killer Cell Lymphomas : p73 Is Consistently Involved
Am. J. Pathol., January 1, 2002; 160(1): 59 - 66.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
G. Fontemaggi, A. Gurtner, S. Strano, Y. Higashi, A. Sacchi, G. Piaggio, and G. Blandino
The Transcriptional Repressor ZEB Regulates p73 Expression at the Crossroad between Proliferation and Differentiation
Mol. Cell. Biol., December 15, 2001; 21(24): 8461 - 8470.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
S. Matsukura, K. Miyazaki, H. Yakushiji, A. Ogawa, K. Harimaya, Y. Nakabeppu, and M. Sekiguchi
Expression and Prognostic Significance ofO6-Methylguanine-DNA Methyltransferase in Hepatocellular, Gastric, and Breast Cancers
Ann. Surg. Oncol., December 1, 2001; 8(10): 807 - 816.
[Abstract] [Full Text] [PDF]

Home page
 Cell Growth Differ.Home page
M. S. Irwin and W. G. Kaelin
p53 Family Update: p73 and p63 Develop Their Own Identities
Cell Growth Differ., July 1, 2001; 12(7): 337 - 349.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Yuan, R. Mendez, A. Sahin, and J. L. Dai
Hypermethylation Leads to Silencing of the SYK Gene in Human Breast Cancer
Cancer Res., July 1, 2001; 61(14): 5558 - 5561.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. A. Nicholson, N. T. Okby, M. A. Khan, J. A. Welsh, M. G. McMenamin, W. D. Travis, J. R. Jett, H. D. Tazelaar, V. Trastek, P. C. Pairolero, et al.
Alterations of p14ARF, p53, and p73 Genes Involved in the E2F-1-mediated Apoptotic Pathways in Non-Small Cell Lung Carcinoma
Cancer Res., July 1, 2001; 61(14): 5636 - 5643.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
J. F Costello and C. Plass
Methylation matters
J. Med. Genet., May 1, 2001; 38(5): 285 - 303.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
M. Esteller, P. G. Corn, S. B. Baylin, and J. G. Herman
A Gene Hypermethylation Profile of Human Cancer
Cancer Res., April 1, 2001; 61(8): 3225 - 3229.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
L. A. Brooks, J. A. Tidy, B. Gusterson, L. Hiller, J. O’Nions, M. Gasco, M. C. Marin, P. J. Farrell, W. G. Kaelin Jr., and T. Crook
Preferential Retention of Codon 72 Arginine p53 in Squamous Cell Carcinomas of the Vulva Occurs in Cancers Positive and Negative for Human Papillomavirus
Cancer Res., December 1, 2000; 60(24): 6875 - 6877.
[Abstract] [Full Text]

Home page
 JNCI J Natl Cancer InstHome page
K. Kawakami, J. Brabender, R. V. Lord, S. Groshen, B. D. Greenwald, M. J. Krasna, J. Yin, A. S. Fleisher, J. M. Abraham, D. G. Beer, et al.
Hypermethylated APC DNA in Plasma and Prognosis of Patients With Esophageal Adenocarcinoma
J Natl Cancer Inst, November 15, 2000; 92(22): 1805 - 1811.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. L. Hecht and J. C. Aster
Molecular Biology of Burkitt's Lymphoma
J. Clin. Oncol., November 1, 2000; 18(21): 3707 - 3721.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
P. G. Corn, B. D. Smith, E. S. Ruckdeschel, D. Douglas, S. B. Baylin, and J. G. Herman
E-Cadherin Expression Is Silenced by 5' CpG Island Methylation in Acute Leukemia
Clin. Cancer Res., November 1, 2000; 6(11): 4243 - 4248.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
B.-J. Park, S.-J. Lee, J. I. Kim, S.-J. Lee, C.-H. Lee, S.-G. Chang, J.-H. Park, and S.-G. Chi
Frequent Alteration of p63 Expression in Human Primary Bladder Carcinomas
Cancer Res., July 1, 2000; 60(13): 3370 - 3374.
[Abstract] [Full Text]

Home page
 Clin. Cancer Res.Home page
M.-J. Kang, B.-J. Park, D.-S. Byun, J.-I. Park, H.-J. Kim, J.-H. Park, and S.-G. Chi
Loss of Imprinting and Elevated Expression of Wild-Type p73 in Human Gastric Adenocarcinoma
Clin. Cancer Res., May 1, 2000; 6(5): 1767 - 1771.
[Abstract] [Full Text]

Home page
 CarcinogenesisHome page
Y. C. Cai, G.-y. Yang, Y. Nie, L.-D. Wang, X. Zhao, Y.-l. Song, D. N. Seril, J. Liao, E. P. Xing, and C. S. Yang
Molecular alterations of p73 in human esophageal squamous cell carcinomas: loss of heterozygosity occurs frequently; loss of imprinting and elevation of p73 expression may be related to defective p53
Carcinogenesis, April 1, 2000; 21(4): 683 - 689.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Hagiwara, M. G. McMenamin, K. Miura, and C. C. Harris
Mutational Analysis of the p63/p73L/p51/p40/CUSP/KET Gene in Human Cancer Cell Lines Using Intronic Primers
Cancer Res., September 1, 1999; 59(17): 4165 - 4169.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
I. Lemasson and J. K. Nyborg
Human T-cell Leukemia Virus Type I Tax Repression of p73beta Is Mediated through Competition for the C/H1 Domain of CBP
J. Biol. Chem., May 4, 2001; 276(19): 15720 - 15727.
[Abstract] [Full Text] [PDF]

Home page
 Genome ResHome page
J.-M. Rouillard, A. E. Erson, R. Kuick, J.-i. Asakawa, K. Wimmer, M. Muleris, E. M. Petty, and S. Hanash
Virtual Genome Scan: A Tool for Restriction Landmark-Based Scanning of the Human Genome
Genome Res., August 1, 2001; 11(8): 1453 - 1459.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.